These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21900903)

  • 1. Patent protection brings hope to insurers.
    Kenyon G
    Nat Med; 2011 Sep; 17(9):1026. PubMed ID: 21900903
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug costs threaten patent protection.
    Cimons M
    Nat Med; 2003 Jan; 9(1):9. PubMed ID: 12514706
    [No Abstract]   [Full Text] [Related]  

  • 3. International patent protection for HIV-related therapies: patent attorney's perspective.
    Pavento LC; Greene JL; McDonald JK
    Emory Int Law Rev; 2003; 17(2):919-31. PubMed ID: 15199935
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug patent protection: how long is long enough?
    Sibbald B
    CMAJ; 2001 May; 164(9):1331. PubMed ID: 11341146
    [No Abstract]   [Full Text] [Related]  

  • 5. Patent fight sparks biological warfare in the drug industry.
    Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
    [No Abstract]   [Full Text] [Related]  

  • 6. Promega changes tack in battle over patent.
    Knight J
    Nature; 2003 Nov; 426(6965):373. PubMed ID: 14647346
    [No Abstract]   [Full Text] [Related]  

  • 7. Patent crunch pending.
    Wadman M
    Nature; 2007 Oct; 449(7163):651. PubMed ID: 17968400
    [No Abstract]   [Full Text] [Related]  

  • 8. A day late and a few million dollars short.
    Goldenson D
    Nat Biotechnol; 2009 Jun; 27(6):538-41. PubMed ID: 19513055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent protection: a need for value-based patents.
    Mardikar HM; Deshpande NV; Ghadyalpatil NS; Mardikar M
    Lancet; 2003 Feb; 361(9357):613. PubMed ID: 12598169
    [No Abstract]   [Full Text] [Related]  

  • 10. The importance of patent term restoration to pharmaceutical innovation.
    Hutt PB
    Health Aff (Millwood); 1982; 1(2):6-24. PubMed ID: 7185724
    [No Abstract]   [Full Text] [Related]  

  • 11. [Novartis should discontinue its patent case in India!].
    PehrOlov P
    Lakartidningen; 2007 Feb 14-20; 104(7):524. PubMed ID: 17375688
    [No Abstract]   [Full Text] [Related]  

  • 12. Patent threat in emerging economies shifts to biotech.
    Jayaranam K
    Nat Biotechnol; 2008 May; 26(5):481-3. PubMed ID: 18464760
    [No Abstract]   [Full Text] [Related]  

  • 13. 18 months sliced off Celebrex's patent protection.
    Harrison C
    Nat Rev Drug Discov; 2014 May; 13(5):326. PubMed ID: 24781542
    [No Abstract]   [Full Text] [Related]  

  • 14. Patent infringement.
    Kempton L
    Nat Rev Drug Discov; 2005 Feb; 4(2):97. PubMed ID: 15756754
    [No Abstract]   [Full Text] [Related]  

  • 15. Patent watch.
    Harrison C
    Nat Rev Drug Discov; 2008 Nov; 7(11):882-3. PubMed ID: 18974746
    [No Abstract]   [Full Text] [Related]  

  • 16. Considerations in vaccine patent protection.
    Brazell L
    IDrugs; 2010 Dec; 13(12):885-9. PubMed ID: 21154148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ; Graham SJ
    Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract]   [Full Text] [Related]  

  • 18. Patent immorality?
    Bloche MG; Jungman ER
    Am J Bioeth; 2002; 2(3):48-9. PubMed ID: 12230859
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms.
    Panattoni LE
    J Health Econ; 2011 Jan; 30(1):126-45. PubMed ID: 21074873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supreme Court rules against drug patent "evergreening".
    Kondro W
    CMAJ; 2006 Dec; 175(12):1508-9. PubMed ID: 17146081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.